Pharmaceutical

The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and potentially blinding condition. It's the first treatment specifically approved for thyroid eye disease. The drug of Horizon Therapeutics was approved by the U.S. Food and Drug Administration and is set to be marketed under the brand name Tepezza. Graves’ Orbitopathy (GO) or Ophthalmopathy or Thyroid eye disease (TED) is an autoimmune disorder. The condition occurs when the same antibody causes thyroid dysfunction, which activates the receptors in the thyroid gland resulting in hyperthyroidism. This affects the eyes causing the inflammation of the eye tissues.  ...